Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.
Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab. Clin Cancer Res. 2007 Feb 15; 13(4):1260-8.